Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Assessment of Retreatment With Lutathera in Patients With New Progression of Intestinal Well-differenciated NET

ABSTRACT: In France, since the reimbursement of Lutathera, this treatment is allowed for retreatment if patients still fulfill the criteria of its indication and 4 news cycles could be proposed. However, clinical practices are heterogeneous regarding the number of new cycles and most teams perform only two additional cycles (every 8 weeks). Therefore, the coordinator propose to evaluate the efficacy of two additional cycle of Lutathera versus active surveillance in patients already retreated with two cycles Lutathera for a new progression of intestinal neuroendocrine tumor and who previously received the 4 cycles of treatment with a clinical benefit.

DISEASE(S): Neuroendocrine Tumors,Progressive Disease,Endocrine Gland Neoplasms,Intestinal Well Differentiated Endocrine Tumor,Neoplasms,Disease Progression

PROVIDER: 2382758 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Json Xml

Similar Datasets

A study to assess the schemas of retreatment with Lutathera in patients with new progression of intestinal well-differentiated neuroendocrine tumor.

Project description:Primary objectives: To evaluate the efficacy of two additional cycles of Lutathera (one injection every two months), compared to active surveillance during 6 months in patients already retreated with two cycles. Primary endpoints: Disease Control Rate at 6 months from randomization (defined as Complete Response, Partial Response and Stable Disease from RECIST v1.1) with an evaluation every 2 months.

| 2541272 | ecrin-mdr-crc

G2 Phase Controls Binary Division of Toxoplasma gondii

Project description:The current study investigates the roles of a novel essential cell cycle kinase TgCrk4. We identified this kinase aalong with its cyclin partner and demonstrated that TgCrk4 regulates processes carried out during conventional G2 phase, such as repression of chromosome re-replication and centrosome re-duplication. Accumulation of TgCyc4 in the nucleus and on the centrosomes, supported the role of TgCrk4-TgCyc4 complex as a coordinator of chromosome and centrosome cycles in T. gondii.

2024-06-23 | PXD050478 | Pride

PCR cycles affect gibbs free energy bias

Project description:We amplified DNA fragments randomly sheared from PER1 BAC library with four different PCR cycles (3, 6, 12, and 18 cycles). We report the effect of Gibbs free energy bias to coverage significantly increases with additional number of PCR cycles, especially for fragments with high Gibbs free energy (usually corresponding to low GC content).

2020-05-06 | GSE149914 | GEO

Single cell analysis reveals mechanisms of heterogeneity and plasticity of leukemia initiating cells [Seq-Well]

Project description:Leukemia initiating cells (LICs) self-renew indefinitely to fuel leukemic growth and spark disease relapse. Previously thought to be primitive and rare, the LIC state may actually be heterogeneous and dynamic, allowing LICs to evade therapy. Here, we use single cell transcriptomics to dissect the ontogeny of MLL-rearranged B-lymphoblastic leukemia (MLL-r B-ALL). Although we identify primitive, rare LICs, we also find more phenotypically differentiated LICs that possess the capability to replenish the full cellular diversity of MLL-r B-ALL. We find that activation of MYC-driven oxidative phosphorylation drives this process of cell state conversion, defining a new mechanism of LIC plasticity.

2022-03-24 | GSE147861 | GEO

Transcriptome analysis of dHey knock down and control enterocytes, as well as isolated enteroblasts

Project description:Gene expression analses of adult female gut and purified gut cells. Using the adult Drosophila gut, we found that the transcription factor dHey is a critical identity coordinator of differentiated enterocytes (EC`combined expression analyses with chromatin binding profiling showed that dHey determines activity of enhancers in order to maintain EC identity, and co-regulates nuclear organization by governing a switch in the expression of nuclear lamins. Moreover, like dHey loss, de-regulated expression of lamins overrode identity programs. Thus, a single TF concomitantly orchestrates chromatin state, enhancer activity, and nuclear organization safeguarding differentiated cell identity. Conditional dHey knock down in enterocytes (EC) results in loss of the differnetated identity of entrocytes and impacts gut homeostasis. In addtion Using purified Enteroblast (EB) we mappaed the changes in gene expression during EB to EC differentiation, and the impact of dhey on the gene expression of EBs. Manuscript title: Specification and maintenance of enterocyte identity requires dHey and nuclear lamins

2019-07-15 | GSE87894 | GEO

Expression data from cardiac-specific miR-100 overexpressing mice

Project description:During heart failure development, cardiac tissue undergoes diverse adaptions, for example on a structural and/or metabolic basis, to fulfill the requirements needed to provide a proper circulation to the whole body. We used microarray analysis to identify possible new targets of microRNA-100 in heart tissue.

2020-09-15 | GSE157926 | GEO

pseudomonas fluorescens LC-MSMS

Project description:our work revealed a rewired regulatory network of mqsA in P. fluoresces, in which a new transcription factor is recruited and incorporated to fulfill the similar physiological function.

2019-01-30 | PXD008578 | Pride

Single cell RNA-sequencing of Spike-ins and mESC using Smart-Seq2 on 96-well plates

Project description:In this study, we assess technical differences between commonly used single-cell RNA-Sequencing (scRNA-Seq) methods. We perform scRNA-seq on a homogenous population of mouse embryonic stem cells along with two kinds of control spike-in molecules to assess sensitivity and accuracy of these specific methods. In this dataset, we assess the RNA-degradation and decay rates by subjecting both spike-in molecules to range of repeated freezing and thawing (freeze-thaw) cycles. We manually add spike-in molecules across a 96-well plate (containing cells and reagents), perform Smart-Seq2 method manually and generate single-cell libraries using Nextera XT kit

2017-03-14 | E-MTAB-5481 | biostudies-arrayexpress

Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with Multiple Myeloma

Project description:BCMA targeting chimeric antigen receptor (CAR) T cell therapy have shown deep and durable responses in multiple myeloma. However, relapse following therapy is frequently observed, and mechanisms of resistance remain ill-defined. We performed single cell genomic characterization of longitudinal samples from a patient who relapsed after initial CAR T cell treatment with lack of response to retreatment.

2021-01-11 | GSE164551 | GEO

DNA-guided transcription factor cooperativity shapes face and limb mesenchyme [RNA-seq]

Project description:Transcription factors (TFs) can define distinct cellular identities despite nearly identical DNA-binding specificities. One mechanism for achieving regulatory specificity is DNA-guided TF cooperativity. Although in vitro studies suggest it may be common, examples of such cooperativity remain scarce in cellular contexts. Here, we demonstrate how ‘Coordinator’, a long DNA motif comprised of common motifs bound by many basic helix-loop-helix (bHLH) and homeodomain (HD) TFs, uniquely defines regulatory regions of embryonic face and limb mesenchyme. Coordinator guides cooperative and selective binding between the bHLH family mesenchymal regulator TWIST1 and a collective of HD factors associated with regional identities in the face and limb. TWIST1 is required for HD binding and open chromatin at Coordinator sites, while HD factors stabilize TWIST1 occupancy at Coordinator and titrate it away from HD-independent sites. This cooperativity results in shared regulation of genes involved in cell-type and positional identities, and ultimately shapes facial morphology and evolution.

2023-05-30 | GSE230318 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data